Keywords: Menarini, Teijin Pharma, Feboxostat, Gout, Central and South Ameica, CIS, Oceania

Menarini extends febuxostat accord to more regions

Article | 12 April 2012

Japanese drugmaker Teijin Pharma and privately-owned Italian pharmaceutical company Menarini have signed an exclusive distributorship agreement for the marketing of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in